Evolus (EOLS) News Today $9.68 +0.12 (+1.26%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$9.62 -0.05 (-0.57%) As of 05/23/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EOLS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Deutsche Bank AG Cuts Stock Holdings in Evolus, Inc. (NASDAQ:EOLS)Deutsche Bank AG cut its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 43.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 307,769 shares of the company's stock after selling 237,820 shares during the period. Deutsche Bank AG owned abouMay 23 at 3:33 AM | marketbeat.comNorthern Trust Corp Purchases 45,384 Shares of Evolus, Inc. (NASDAQ:EOLS)Northern Trust Corp raised its position in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 9.3% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 531,167 shares of the company's stock after acquiring an additional 45,384 shares during the periodMay 23 at 3:09 AM | marketbeat.comZimmer Partners LP Boosts Holdings in Evolus, Inc. (NASDAQ:EOLS)Zimmer Partners LP increased its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 66.6% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 416,500 shares of the company's stock after buying an additional 166,500 shares during the quarter.May 22 at 6:08 AM | marketbeat.comSoleus Capital Management L.P. Has $7.70 Million Stake in Evolus, Inc. (NASDAQ:EOLS)Soleus Capital Management L.P. decreased its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 32.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 697,158 shares of the company's stock after selling 340,522 shaMay 21 at 8:08 AM | marketbeat.comStonepine Capital Management LLC Cuts Stock Position in Evolus, Inc. (NASDAQ:EOLS)Stonepine Capital Management LLC cut its position in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 7.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,264,651 shares of the company's stock after selling 105,17May 20, 2025 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) Shares Bought by Tang Capital Management LLCTang Capital Management LLC lifted its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,997,399 shares of the company's stock after buying an additional 150,000 sharMay 20, 2025 | marketbeat.comComerica Bank Purchases New Stake in Evolus, Inc. (NASDAQ:EOLS)Comerica Bank purchased a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 28,301 shares of the company's stock, valued at approximately $312May 19, 2025 | marketbeat.com68,181 Shares in Evolus, Inc. (NASDAQ:EOLS) Bought by Jefferies Financial Group Inc.Jefferies Financial Group Inc. acquired a new position in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 68,181 shares of the comMay 18, 2025 | marketbeat.comGraham Capital Management L.P. Has $518,000 Stock Holdings in Evolus, Inc. (NASDAQ:EOLS)Graham Capital Management L.P. lifted its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 289.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 46,963 shares of the company's stock after acquiring an additional 34,907 sharesMay 18, 2025 | marketbeat.comCubist Systematic Strategies LLC Reduces Position in Evolus, Inc. (NASDAQ:EOLS)Cubist Systematic Strategies LLC decreased its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 80.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 47,438 shares of the company's stock after selling 194,604 shares duriMay 18, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 122,094 Shares of Evolus, Inc. (NASDAQ:EOLS)D. E. Shaw & Co. Inc. reduced its holdings in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 12.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 848,176 shares of the company's stock after selling 122,094May 17, 2025 | marketbeat.comEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 16, 2025 | businesswire.comEvolus, Inc. (NASDAQ:EOLS) Insider David Moatazedi Sells 15,787 SharesMay 16, 2025 | insidertrades.comEvolus, Inc. (NASDAQ:EOLS) Insider Rui Avelar Sells 3,385 SharesMay 15, 2025 | insidertrades.comEvolus, Inc. (EOLS): A Bull Case TheoryMay 13, 2025 | msn.comFrontier Capital Management Co. LLC Invests $2.65 Million in Evolus, Inc. (NASDAQ:EOLS)Frontier Capital Management Co. LLC bought a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 239,811 shares of the company's stock, valued at approximately $2,648,000. FrontierMay 12, 2025 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This YearMay 10, 2025 | uk.finance.yahoo.comEvolus (NASDAQ:EOLS) Earns Buy Rating from Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $22.00 price objective on shares of Evolus in a report on Thursday.May 10, 2025 | marketbeat.comRaymond James Financial Inc. Acquires Shares of 52,035 Evolus, Inc. (NASDAQ:EOLS)Raymond James Financial Inc. bought a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 52,035 shares of the company's stock, valued at approximatelMay 10, 2025 | marketbeat.com5EOLS : What Analysts Are Saying About Evolus StockMay 8, 2025 | benzinga.comEvolus Inc (EOLS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market ChallengesMay 8, 2025 | finance.yahoo.comEvolus Reports First Quarter 2025 ResultsMay 7, 2025 | businesswire.comEvolus, Inc. (NASDAQ:EOLS) Shares Acquired by Stifel Financial CorpStifel Financial Corp boosted its position in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 37.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 197,697 shares of the company's stock after buyingMay 7, 2025 | marketbeat.comEvolus Q1 2025 Earnings PreviewMay 6, 2025 | msn.comEvolus, Inc. (NASDAQ:EOLS) Shares Sold by Invesco Ltd.Invesco Ltd. decreased its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 81.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 18,326 shares of the company's stock after selling 83,072 shares during the quarter. InvescMay 6, 2025 | marketbeat.comLeerink Partnrs Forecasts Evolus' Q1 Earnings (NASDAQ:EOLS)Evolus, Inc. (NASDAQ:EOLS - Free Report) - Investment analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for Evolus in a research note issued to investors on Wednesday, April 30th. Leerink Partnrs analyst M. Goodman forecasts that the company will earn ($0.24) per share for the quarteMay 6, 2025 | marketbeat.comEvolus Secures New $250 Million Credit FacilityMay 5, 2025 | tipranks.comEvolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial FlexibilityMay 5, 2025 | businesswire.comAllostery Investments LP Takes Position in Evolus, Inc. (NASDAQ:EOLS)Allostery Investments LP bought a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 431,117 shares of the company's stock, valued at approximately $4,760,000. EvolMay 4, 2025 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) Shares Bought by Caligan Partners LPCaligan Partners LP grew its holdings in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 22.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,692,388 shares of the company's stock after purchasing anMay 3, 2025 | marketbeat.comEvolus (EOLS) Projected to Post Earnings on WednesdayEvolus (NASDAQ:EOLS) will be releasing its Q1 2025 earnings after the market closes on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-evolus-inc-stock/)May 2, 2025 | marketbeat.comSoros Fund Management LLC Raises Stake in Evolus, Inc. (NASDAQ:EOLS)Soros Fund Management LLC lifted its position in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 29.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,100,000 shares of the company's stock after purchasing an additional 250,000 shares during the qMay 1, 2025 | marketbeat.comEvolus (NASDAQ:EOLS) Stock Price Down 5.7% - Here's WhyEvolus (NASDAQ:EOLS) Trading Down 5.7% - Should You Sell?April 30, 2025 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) is Nantahala Capital Management LLC's 9th Largest PositionNantahala Capital Management LLC lifted its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 10.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,130,149 shares of the company's stock after buying an addiApril 30, 2025 | marketbeat.comLord Abbett & CO. LLC Trims Stock Position in Evolus, Inc. (NASDAQ:EOLS)Lord Abbett & CO. LLC trimmed its position in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 50.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 497,849 shares of the company's stock after selling 497,600 sharApril 30, 2025 | marketbeat.com742,574 Shares in Evolus, Inc. (NASDAQ:EOLS) Bought by Tri Locum Partners LPTri Locum Partners LP bought a new stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 742,574 shares of the company's stock, valued at approximately $8,198,000. EvApril 29, 2025 | marketbeat.comGilder Gagnon Howe & Co. LLC Purchases 520,859 Shares of Evolus, Inc. (NASDAQ:EOLS)Gilder Gagnon Howe & Co. LLC raised its position in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 287.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 702,239 shares of the company's stock after acquiring an additional 520,859 shares durinApril 29, 2025 | marketbeat.comBoothbay Fund Management LLC Buys 304,065 Shares of Evolus, Inc. (NASDAQ:EOLS)Boothbay Fund Management LLC raised its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 30.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,287,767 shares of the company'April 28, 2025 | marketbeat.comJPMorgan Chase & Co. Lowers Position in Evolus, Inc. (NASDAQ:EOLS)JPMorgan Chase & Co. trimmed its position in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 18.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 138,149 shares of the company's stock after selling 31,777 sharesApril 28, 2025 | marketbeat.comJump Financial LLC Sells 31,687 Shares of Evolus, Inc. (NASDAQ:EOLS)Jump Financial LLC decreased its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 42.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 43,100 shares of the company's stock after selling 31,687 sharesApril 27, 2025 | marketbeat.comOberweis Asset Management Inc. Increases Stock Position in Evolus, Inc. (NASDAQ:EOLS)Oberweis Asset Management Inc. boosted its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 31.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 677,600 shares of the company's stock afterApril 26, 2025 | marketbeat.comDiadema Partners LP Takes Position in Evolus, Inc. (NASDAQ:EOLS)Diadema Partners LP bought a new position in Evolus, Inc. (NASDAQ:EOLS - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 97,423 shares of the company's stock, valued at approximately $1,076,000. Diadema Partners LP owned 0.15%April 24, 2025 | marketbeat.comEversept Partners LP Decreases Stock Holdings in Evolus, Inc. (NASDAQ:EOLS)Eversept Partners LP cut its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 15.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 383,045 shares of the company's stock after selling 70April 24, 2025 | marketbeat.comEvolus: Two-Product Aesthetics Company With A Competitive EdgeApril 22, 2025 | seekingalpha.comFormula Growth Ltd. Lowers Holdings in Evolus, Inc. (NASDAQ:EOLS)Formula Growth Ltd. reduced its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 34.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 90,830 shares of the company's stock after selling 47,170 shaApril 21, 2025 | marketbeat.comEvolus, Inc. (NASDAQ:EOLS) Shares Bought by Altium Capital Management LLCAltium Capital Management LLC lifted its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 93.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 685,000 shares of the company's stock after purchasing an additionApril 20, 2025 | marketbeat.comEvolus (NASDAQ:EOLS) Shares Gap Up - Here's WhyEvolus (NASDAQ:EOLS) Shares Gap Up - Here's What HappenedApril 19, 2025 | marketbeat.comEvolus (NASDAQ:EOLS) Now Covered by Analysts at BTIG ResearchBTIG Research initiated coverage on shares of Evolus in a research report on Thursday. They issued a "buy" rating and a $21.00 price objective on the stock.April 19, 2025 | marketbeat.comEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 18, 2025 | businesswire.comBTIG Initiates Coverage of Evolus (EOLS) with Buy RecommendationApril 18, 2025 | msn.com Get Evolus News Delivered to You Automatically Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter. Email Address EOLS Media Mentions By Week EOLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EOLS News Sentiment▼1.520.73▲Average Medical News Sentiment EOLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EOLS Articles This Week▼114▲EOLS Articles Average Week Get Evolus News Delivered to You Automatically Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MoonLake Immunotherapeutics News Today Immunovant News Today ImmunityBio News Today Xenon Pharmaceuticals News Today Amneal Pharmaceuticals News Today HUTCHMED News Today Organon & Co. News Today Mirum Pharmaceuticals News Today Apellis Pharmaceuticals News Today Arrowhead Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EOLS) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredThe “black glass” breakthrough behind AI’s next leapAI is advancing fast… But there’s one problem almost no one’s talking about. Power.True Market Insiders | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EOLS Stock Free EOLS Stock Alerts